ArticleThe Journal of investigative dermatology2022

IL-32 Supports the Survival of Malignant T Cells in Cutaneous T-cell Lymphoma.

Kenneth K Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.